Patient Enrolled in Advanced Cell Technology’s Stem Cell Clinical Trial Shares Her Story
August 6, 2012
Maurie Hill, a young woman with Stargardt’s disease, was accepted into the embryonic stem cell clinical trial being run by Advanced Cell Technology (Nasdaq: ACTC) at Wills Eye Institute in Philadelphia. She was the first patient to receive the higher dose of 100K of RPE cells derived from human embryonic stem cells.
On her blog, she describes her experiences. To read her story, please follow this link.
Jump down to form below to submit your own comments